NCT05417386 2025-11-18
FOLFIRINOX + NIS793 in Pancreatic Cancer
Massachusetts General Hospital
Phase 1 Terminated
Clinical Trials
9 trialsNCT03527264 2025-04-04
BrUOG 355: Nivolumab to Tailored Radiation Therapy With Concomitant Cisplatin in the Treatment of Patients With Cervical Cancer
Brown University
Phase 2 Terminated
NCT05546411 2024-12-17
A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer
Dana-Farber Cancer Institute
Phase 2 Terminated
NCT04958993 2022-02-25
A Trial of Anlotinib Combined With Concurrent Chemoradiotherapy in Patients With Unresectable Stage III Non-small Cell Lung Cancer
Shandong Cancer Hospital and Institute
Phase 1/2 Terminated
NCT02716896 2019-11-25
Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder Cancer
The University of Texas Health Science Center at San Antonio
Phase NA Terminated
NCT02233595 2019-08-13
Rectal PET/MRI
University of California, San Francisco
Terminated
NCT00431613 2015-05-29
Study of Docetaxel/Gemcitabine Followed by Chemo-radiotherapy (Chemo-RT), With or Without Consolidation Chemotherapy, in IIIA/IIIB Non Small Cell Lung Cancer (NSCLC)
Hellenic Oncology Research Group
Phase 2 Terminated
NCT00831493 2012-02-28
Vorinostat Plus Radiation Therapy in Pancreatic Cancer
M.D. Anderson Cancer Center
Phase 1/2 Terminated
NCT00169221 2011-11-15
Post-operative Radiotherapy With Cisplatin Alone or in Combination With Iressa in Upper Aerodigestive Tract Carcinomas
Groupe Oncologie Radiotherapie Tete et Cou
Phase 2 Terminated